Publication:
P53 Her2/neu as prognostic factors in advanced non-small cell lung cancer (NSCLC) treated with paclitaxel

Simple item page
dc.contributor.authorsYumuk, R; Turhal, N; Ahiskali, R; Gumus, M; Hatabay, N; Turken, O; Ozkan, A; Salepci, T; Aliustaoglu, M
dc.date.accessioned2022-03-12T15:59:39Z
dc.date.accessioned2026-01-10T19:39:18Z
dc.date.available2022-03-12T15:59:39Z
dc.date.issued2005
dc.identifier.doidoiWOS:000231307801061
dc.identifier.issn0169-5002
dc.identifier.urihttps://hdl.handle.net/11424/224469
dc.identifier.wosWOS:000231307801061
dc.language.isoeng
dc.publisherELSEVIER IRELAND LTD
dc.relation.ispartofLUNG CANCER
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleP53 Her2/neu as prognostic factors in advanced non-small cell lung cancer (NSCLC) treated with paclitaxel
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS152
oaire.citation.startPageS152
oaire.citation.titleLUNG CANCER
oaire.citation.volume49

Files

Collections

Araştırma Çıktıları